Newbury Pharmaceuticals AB Company Description

Newbury Pharmaceuticals AB (publ) operates as hybrid pharmaceutical company in Sweden and the Scandinavian market.

The company offers oncology, rare diseases, neurology, and other treatment products. Newbury Pharmaceuticals AB (publ) was incorporated in 2020 and is based in Lund, Sweden.

Newbury Pharmaceuticals AB (publ)

Country	Sweden
Founded	2020
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	5
CEO	Lars Minor

Contact Details

Address: Medicon Village Lund, 223 81 Sweden
Phone	46 46 12 11 20
Website	newburypharma.com

Stock Details

Ticker Symbol	NEWBRY
Exchange	Nasdaq Stockholm
Fiscal Year	September - August
Reporting Currency	SEK
ISIN Number	SE0015244884
SIC Code	2834

Key Executives

Name	Position
Lars Minor	Chief Executive Officer
Karl Alexius Tiger Karlsson	Founder and Executive Chairman
Christoffer Tell	Chief Financial Officer
Fredrik Hellqvist	Vice President of Sales and Marketing